Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?
Bill of Health
JANUARY 6, 2022
The National Institutes of Health (NIH) is currently embroiled in a dispute over the ownership of patent rights to Moderna’s flagship mRNA COVID-19 vaccine (mRNA-1273). Failing to do so would be a missed opportunity for the public sector to have a say in the distribution and pricing of this critical medical technology.
Let's personalize your content